Recently, researchers delivered Ldlr mRNA encapsulated in EVs to hepatocytes, restoring Ldlr function in a transgenic mouse model of hypercholesterolemia and significantly lowering serum LDL-cholesterol as compared to control animals treated with PBS or empty EVs (Figure 10A-B) 133. This evidence concerns the gene LDLR and Hypercholesterolemia.